Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Radius Health

    Client Virtual Booth

    RADIUS HEALTH

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Radius Health
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    950 Winter Street Waltham, MA 02451
    Telephone
    Telephone
    617-551-4000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://radiuspharm.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/radius-health-inc/
    Twitter
    Twitter
    https://twitter.com/Radius_Health

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    US FDA grants approval for Radius’ Tymlos for osteoporosis in men
    US FDA grants approval for Radius’ Tymlos for osteoporosis in men

    https://www.pharmaceutical-technology.com/news/fda-radius-tymlos-osteoporosis/

    PHARMACEUTICAL-TECHNOLOGY
    22 Dec 2022
    Share Share
    EU Moment of Truth For Abaloparatide & Advanced Therapy Tab-Cel
    EU Moment of Truth For Abaloparatide & Advanced Therapy Tab-Cel

    https://pink.pharmaintelligence.informa.com/PS147138/EU-Moment-of-Truth-For-Abaloparatide--Advanced-Therapy-TabCel

    PHARMAINTELLIGENCE
    11 Oct 2022
    Share Share
    Gurnet Point & Patient Square Complete Their Acquisition of Radius Health
    Gurnet Point & Patient Square Complete Their Acquisition of Radius Health

    https://www.globenewswire.com/news-release/2022/08/15/2498274/31149/en/Gurnet-Point-Capital-and-Patient-Square-Capital-Complete-Their-Acquisition-of-Radius-Health-Inc.html

    GLOBENEWSWIRE
    15 Aug 2022
    Share Share
    Menarini Group’s Elacestrant Granted Priority Review by the U.S. FDA
    Menarini Group’s Elacestrant Granted Priority Review by the U.S. FDA

    https://www.businesswire.com/news/home/20220811005185/en

    BUSINESSWIRE
    11 Aug 2022
    Share Share
    Radius Health Publishes Investor Presentation Outlining Company's Progress
    Radius Health Publishes Investor Presentation Outlining Company's Progress

    https://www.globenewswire.com/news-release/2022/07/07/2476330/31149/en/Radius-Health-Publishes-Investor-Presentation-Outlining-Company-s-Progress-and-Board-Process-Resulting-in-Agreement-to-be-Acquired-at-Significant-Premium.html

    GLOBENEWSWIRE
    07 Jul 2022
    Share Share
    Radius Announces First Patient Randomized in RAD011 Pivotal Trial for PWS
    Radius Announces First Patient Randomized in RAD011 Pivotal Trial for PWS

    https://www.globenewswire.com/news-release/2022/07/07/2475806/31149/en/Radius-Announces-First-Patient-Randomized-in-the-RAD011-Pivotal-Trial-for-Prader-Willi-Syndrome.html

    GLOBENEWSWIRE
    07 Jul 2022
    Share Share
    2 investment firms buy Radius, bone drug Tymlos for $890M
    2 investment firms buy Radius, bone drug Tymlos for $890M

    https://www.fiercepharma.com/pharma/radius-health-bought-out-two-investment-firms-890-million

    Kevin Dunleavy FIERCEPHARMA
    24 Jun 2022
    Share Share
    Menarini Group and Radius Health Submit NDA to the U.S. FDA for Elacestrant
    Menarini Group and Radius Health Submit NDA to the U.S. FDA for Elacestrant

    https://www.prnewswire.com/news-releases/menarini-group-and-radius-health-submit-new-drug-application-to-the-us-fda-for-elacestrant-301573553.html

    PRNEWSWIRE
    22 Jun 2022
    Share Share
    Radius Health Expands Non-US Market Footprint for TYMLOS
    Radius Health Expands Non-US Market Footprint for TYMLOS

    https://www.globenewswire.com/news-release/2022/06/08/2458699/31149/en/Radius-Health-Expands-Non-US-Market-Footprint-for-TYMLOS.html

    GLOBENEWSWIRE
    08 Jun 2022
    Share Share
    Activist investors attempt to change the course at Radius Health
    Activist investors attempt to change the course at Radius Health

    https://endpts.com/activist-investors-attempt-to-change-the-course-at-radius-health-six-months-after-two-disappointing-readouts/

    Max Gelman ENDPTS
    07 Jun 2022
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search